supp.fit
All Fish Oil study protocols

Fish Oil, Vitamin E, Omega-3 Fatty Acids and Docosahexaenoic Acid: study protocols

4 study groups took Fish Oil together with Vitamin E, Omega-3 Fatty Acids and Docosahexaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Fish Oil: what the research found →

Fewer than 5 study groups in one unit match, too few to draw the chart.

Commonly used together

2 of 4 study groups took Fish Oil, Vitamin E, Omega-3 Fatty Acids and Docosahexaenoic Acid with something else, but nothing that 3 or more different studies gave.

4 study groups

Study
The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial
2020 · fish oil group · Adults aged 30–54 years with low dietary EPA and DHA intake and no stated diagnosed condition
2 g10 IU1 g400 mg18 weeks134
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
2 g7.6 mg1.42 g480 mg12 weeks40
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
9 g205 mg2.1 g1.1 g12 weeks—
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
1.05 g400 IU1.05 g200 mg—10
Fish Oil, Vitamin E, Omega-3 Fatty Acids and Docosahexaenoic Acid: study protocols | supp.fit